The cellular proto-oncogene c-mvc is known to be involved in the regulation of cell growth and differentiation (for review see Cole. 1986 ). The level of c-mwc RNA is invariably higher in proliferating than in quiescent cells. and remains roughly constant throughout the cell cycle (Thompson et al.. 1985) . C-mvc RNA is markedly induced upon stimulation of resting cells by mitogens to pass from Go to G1 (Kelly et al.. 1983 : Campisi et al.. 1984 . In complementary experiments. c-mvc RNA levels fall dramatically when cells withdraw from the cell cycle into Go or undergo terminal differentiation (for review see Spencer & Groudine. 1990 ). Steady state levels of c-m} c RNA are subject to distinct control mechanisms: exceptionally short half-life of c-mvc RNA (Dani et al.. 1984 : Piechaczyk et al.. 1987 . impaired maturation of the primanr transcript (Eick. 1990) . and a block to RNA-elongation at the first exon-intron border (Bentley & Groudine. 1986a : Eick & Bornkamm. 1986 as rapid means of c-mwc regulation. and modulation of the rate of initiation as a late acting mechanism (Siebenlist et al.. 1988) .
The structure of the gene with two major. PI and P2 (Battey et al.. 1983) . and two minor. P; and P0 (Bentley & Groudine. 1986a : ar-Rushdi et al.. 1983 Hayday et al.. 1984; Bentley & Groudine. 1986b) . sites of transcription initiation has been well characterised. Additionally. positive and negative regulatory elements have been found within or flanking the human and mouse c-m} c gene : Chung et al.. 1986 : Remmers et al.. 1986 : Lipp et al.. 1987 : Kakkis & Calame. 1987 : Hay et al.. 1987 : Iguchi-Ariga et al.. 1988 Weisinger et al.. 1988 : Hall. 1990 ) which may modulate initiation (Thalmeier et al.. 1989 : Pietenpol et al.. 1990 ; Hall. 1990 ; Sacca & Cochran. 1990 ) and elongation of transcription (Bentley & Groudine. 1988 : Miller et al.. 1989 . Several transcription factors have been described which bind to sequences upstream of c-myc including NFl (Siebenlist et al.. 1984) , AP2 (Imagawa et al.. 1987) . APl. and octamer binding factors (Takimoto et al.. 1989 : Hay et al.. 1989 . NFkB (Duyao et al.. 1990) . and a mouse plasmacytoma specific repressor protein (Kakkis et al.. 1989) .
Stimuli from steroid hormones are generally considered to have a key-role in regulating cell proliferation and tissue development. Despite the increasing molecular data on steroid hormone-receptor complex action on individual response elements (for review see Beato. 1989) . until no%. the intricate cell-biological processes leading from hormonal signals to the modulation of cell proliferation remain poorlv defined. Cell cycle arrest associated with c-m! c downregulation by steroid hormones has hitherto been described in lymphocytes and promyelocytes. Glucocorticoids block lymphocytes and lymphoma cells at the G1 phase of the cell cycle. Among a panel of known growth-related genes. only c-m} c expression was reduced by dexamethasone (Yuh & . In a T lymphoblastic leukaemic cell line. immediate post-transcriptional down-regulation of c-mwc has been demonstrated in response to glucocorticoids (Maroder et al.. 1990) .
In the promyelocytic cell line HL60. 1.215-Dihvdroxvvitamin D, (1.25-(OH)Dd>-induced differentation along the monocyte lineage is preceded by a decrease in the steadv state level of c-mwc RNA (Reitsma et al.. 1983) . The 1.25-(OH)2D3 effect on c-mvc RNA was shown to occur at the transcnptional level (Simpson et al.. 1987) .
Androgen analogues containing a 17x-methyl-testosterone backbone inhibit the proliferation (Sonnenschein et al.. 1989) and suppress the transformed phenotype (Wolf et al.. 1991) in the androgen responsive (Horoszewicz et al.. 1983 : Schulz et al.. 1985 : Berns et al.. 1986 ) human prostate carcinoma cell line LNCaP (Horoszewicz et al.. 1980) . The androgen receptor of LNCaP cells carries a point mutation in the steroid binding domain but activates transcription in an androgendependent manner (Veldscholte et al.. 1990 ). LNCaP cells are considered to be the best-suited in *itro model of prostate cancer available (Thompson. 1990 ). Recently we could show that the synthetic androgen mibolerone represses anchorageindependent growth and concomitantly reduces the level of c-mwc RNA in LNCaP cells (Wolf et al.. 1991 RNA extraction and Northern blor analysis Standard protocols were followed as described elsewhere (Wolf et al.. 1991 Nuclear run-on anal!ysis Preparation of nuclear extracts and the hybridisation procedure were performed as described (Eick & Bornkamm. 1986) with slight modifications. 2 x 10' cells were scraped from culture dishes and washed twice in PBS. Cells were resuspended in 10 mm Tris-HCl. pH 7.4. 10 mm NaCl. 3 mM MgC1.. 0.5% (v v) NP40 and incubated on ice for 5 mmn. The nuclear pellets were spun down at 500 g and washed by resuspension in 10 ml of the same buffer. The pelleted nuclei were resuspended in storage buffer (50 mm Tris-HCl. pH 8.3. 40% (v v) (Figure 2c ) at the same concentration ratio (1:750 w w) at which the growth inhibiting effect of androgens on LNCaP cells is reversed (Wolf et al.. 1991) . This finding indicates that the androgen receptor is involved in the signal transduction chain leading to c-mvc down-regulation and to inhibition of proliferation by synthetic androgen.
The levels of PI, P., and P0 transcripts decline, whereas P3 transcripts remain almost constant In order to resolve the contribution of the four known c-mvc promoters to the steady-state c-mvc signal seen in Northern blots, we performed nuclease SI protection assays with probes derived from the promoter region of the human c-mvc gene. Southern analysis of the c-mvc locus of LNCaP cells revealed no rearrangement or amplification (data not shown). Therefore. the expected sizes of SI protected fragments were calculated on the basis of the germline configuration of the human c-m} c gene. As shown in Figure 3a. P0 transcripts are reduced to the same extent (Figure 3a) . In contrast, P3 transcripts which comprise only 3/5% of the total c-myc transcripts in LNCaP cells, remain at a level almost equal to controls in the presence of mibolerone (Figure 3b) . Regulation of the P3-promoter independently of the P0-PI-, and P2-promoter has recently been reported for the normal c-myc allele in the Burkitt's lymphoma cell line Raji 
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Figue 3 C-mwc promoter usage in LNCaP cells. The RNAs described in Figure 2a were subjected to SI analysis with probes specific for the four c-mvc promoters P0, P1. P. and P3. RNA derived from the P0-promoter was indirectly. RNA derived from promoter P1 and P. directly visualised by a uniformly labelled. single-stranded SmaI-PvuII probe (probe a, Figure 1 (Eick et al., 1985) .
C-myc is down-regulated at the level of transcription initiation C-myc RNA is subject to an unusually rapid turnover (Dani et al., 1984) . In several cellular systems, c-myc RNA stability is the primary control mechanism to modulate steady-state levels (for review see Piechaczyk et al., 1987 In the presence of mibolerone, the density and distribution of RNA polymerases on the c-myc gene remained unchanged for the first 3 h. Subsequently, transcriptional activity declined over a period of 2 days to about 10% of controls. The transcription of exon 1 and exon 2 slowed down with a similar rate. However the data presented in Figure 4 do not rule out a contribution of the RNA-elongation block for c-myc down-regulation between 6 and 12h. In the presence of mibolerone and antihormone, transcription of c-myc was unaffected over a period of 2 days (data not shown).
The transcription rate for the PSA (prostate-specific antigen [Schulz et al., 1988D gene was increased 3 h after addition of mibolerone and subsequently declined towards pretreatment levels after 4 days (Figure 4) LNCaP cells: inhibition of proliferation, abrogation of anchorage-independent growth, morphological change, and reduction of c-myc RNA levels (Wolf et al., 1991 (Rories et al., 1989) , and in the murine lymphosarcoma cell line P1798 (Forsthoefel & Thompson, 1987) . A direct transcriptional repression of the murine c-m)c gene by binding of the glucocorticoid receptor complex to a response element upstream of exon 1 has been discussed as a possible mechanism of c-myc shutoff (Forsthoefel & Thompson, 1987) .
The response elements for the glucocorticoid and androgen receptor share the imperfect palindrome GGTACANN-NTGTTCT (Beato, 1989) . In the androgen-regulated C3 gene of rat prostate androgen response is conferred by an element in the first intron (Claessens et al., 1989) . This element AGTACGTGATGTTCT differs in only two positions of the left hand part to the consensus sequence. The first intron of the c-m}vc gene harbours also a potential glucocorticoid/ androgen receptor binding site GGTAGCAGCTG1TCT which diverges in two positions. All elements have the TGT-TCT motif in common which has been shown to be functionally important for glucocorticoid and androgen response. Whether glucocorticoid and androgen receptors can bind to the described element in the first intron of c-mvc has yet to be proven.
Alternatively, steroid-receptor complexes may exert their negative effect on c-my expression without direct binding to
In vivo androgen has a key-role in the maintenance of prostate cells. The hormone preserves the differentiated state of the cells and represses c-mvc. High expression of c-mvc accomphshed by a retroviral vector results in benign hyperplasia in a reconstituted prostate model . Thus, regulation of c-myc in prostate cells by androgen is evident. However, the precise role of c-mi)c in growth control of normal and neoplastic prostate cells remains to be elucidated. 
